KPRX

KIORA PHARMACEUTICALS INC

• TipRanks·05/18 20:35

  Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders

• Benzinga·05/18 20:35

  Kiora Pharmaceuticals Files Prospectus For Offering 11.797M Common Stock On Behalf Of Selling Shareholders

• Reuters·05/18 20:32

  KIORA PHARMACEUTICALS INC - FILES PROSPECTUS FOR RESALE OF UP TO 11.8 MLN SHARES BY SELLING STOCKHOLDERS - SEC FILING

• TipRanks·05/09 21:30

  Analysts Are Bullish on Top Healthcare Stocks: Kiora Pharmaceuticals (KPRX), Myomo (MYO)

• Benzinga·05/08 13:54

  Kiora Pharmaceuticals Q1 EPS $(0.58) Beats $(0.71) Estimate

• Seeking Alpha·05/08 11:25

  Kiora Pharmaceuticals GAAP EPS of -$0.58

• Reuters·05/08 11:10

  KIORA PHARMACEUTICALS INC - Q1 LOSS PER SHARE $0.58 - SEC FILING

• PUBT·04/14 11:08

  Kiora starts Phase 2 ABACUS-2 trial of KIO-301 in retinitis pigmentosa

• Benzinga·04/13 21:05

  12 Health Care Stocks Moving In Monday's After-Market Session

• Reuters·04/09 11:35

  Plus Therapeutics names Eric Daniels chief development officer to advance clinical pipeline

• TipRanks·04/08 18:15

  Strategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)

• Benzinga·04/08 17:05

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• NASDAQ·04/07 14:01

  Kiora Pharma Closes Private Placement For Up To $24 Mln; Stock Up

• Benzinga·04/07 12:05

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• TipRanks·04/07 11:30

  Kiora Pharmaceuticals Announces $5 Million Private Placement Financing